All online payments made to Medica should be done using a patient portal or patient mobile apps only. Medica has no other online payment methods and will never ask to share OTPs over the phone. Be aware, be safe from online fraud activities. For any queries, call: 033 6652 0000
Clinical Trial

Closed Clinical Trial

Closed Clinical Trial

1. A Non-interventional, multicentre study to assess prevalence of BRCA1 and BRCA2 mutation among ovarian, primary peritoneal and fallopian tube cancer patients in India (BRCA STUDY).

2. A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Study of Baricitinib in Patients with COVID-19 Infection. (I4V-MC-KHAA).

3. Phase 2, randomized, controlled, open label multi-center study to assess efficacy and safety of DFV890 for the treatment of SARS-CoV-2 infected patients with COVID-19 pneumonia and impaired respiratory function.(CDFV890D12201)

4. A two arm, randomized, multicentric, open label, efficacy and safety study of Docetaxel Lipid Suspension (DLS) for Injection of Intas Pharmaceuticals Limited, India in Non-Small Cell Lung Cancer patients.

5. A Phase 3, Multicenter, Multinational, Randomized, Open-Label, Parallel-Arm Study Of Avelumab* (Msb0010718c) Plus Best Supportive Care Versus Best Supportive Care Alone As A Maintenance Treatment In Patients With Locally Advanced Or Metastatic Urothelial Cancer Whose Disease Did Not Progress After Completion Of First-Line Platinum-Containing Chemotherapy.( B9991001).

6. A Double-Blind, Randomized, Active-Controlled, Parallel-Group, Phase 3 Study to Compare Efficacy and Safety of CT-P16 and EU-Approved Avastin® as First-Line Treatment for Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer. (CT-P16 3.1)

7. A Randomized, double-blind, placebo-controlled, study evaluating the efficacy and safety of Otilimab IV in patients with severe pulmonary COVID-19 related disease.( OSCAR )

8. A Phase III, Randomized, Controlled, Open-Label Study to Evaluate the Efficacy and Safety of Pegylated Interferon Alfa-2b In the Treatment of Adult Patients Diagnosed With SARS-CoV-2 (COVID-19).(PEGI)

Medica Superspecialty Hospital Request Appointment Medica Superspecialty Hospital Call Us